The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections.
from FDA Press Releases RSS Feed https://ift.tt/305v1Wu
via IFTTT
No comments:
Post a Comment